CapsoVision (CV) Assets Average (2025)

CapsoVision (CV) reported Assets Average of $21.9 million for Q4 2025, up 24.47% sequentially from $17.6 million in Q3 2025.

CapsoVision (CV) Assets Average (2025) Analysis & Trends

CapsoVision (CV) has 1 years of Assets Average data on file, last reported at $21.9 million in Q4 2025.

For the quarter ending Q4 2025, Assets Average changed N/A year-over-year to $21.9 million; the trailing twelve-month figure through Dec 2025 stood at $21.9 million (changed N/A YoY), and the FY2025 full-year result was $17.5 million, changed N/A from the prior year.
Assets Average advanced to $21.9 million in Q4 2025, from $17.6 million in the prior quarter.
In the past five years, Assets Average ranged from a high of $21.9 million in Q4 2025 to a low of $13.2 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	98.57 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	47.07 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	92.26 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	44.01 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	13.51 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	6.49 Bn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	31.64 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	37.02 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	10.57 Bn
10	CapsoVision	162.07 Mn	151.95 Mn	1.95 Mn	21.91 Mn

Download Data